CARE™ Global Interview Series

Updates from 2019 and Their Impact on Current CLL Treatment

With Dr. Matthew S. Davids

Hematology

09 Apr 2020

Recent advancements in the CLL treatment landscape have prompted members of the CARE™ Faculty to discuss how these developments have affected the practice of KOLs across the globe. CARE™ Faculty recently spoke with Dr. Matthew Davids to explore how data released in 2019 have impacted CLL practice.

This issue of the CARE™ Global Interview Series includes content on:

1. Front-line CLL

  • CLL14 
  • ELEVATE TN
  • ALLIANCE
  • ECOG1912

2. Relapsed/Refractory CLL

  • ASCEND
  • MURANO
  • TRANSCEND CLL 004

While CARE™ Content is typically framed from a Canadian Perspective, this series provides insights from global leaders. Content is presented in the format in which it was discussed and is a paraphrase of interview dialogue.